Prostate cancer is associated with high mortality among men. The major factors increasing the risk of the disease constitute of old age, heredity, lifestyle aspects such as smoking and diet rich in red meat. Cancer- digital rectal exam (DRE), prostate biopsy, prostate specific antigen (PSA) blood test, bone scan, ultrasound, CT scan, MRI, lymph node biopsy and ProstaScint monoclonal antibody scan are generally used for diagnosis of prostate cancer. Laparoscopy, cryosurgery, brachytherapy and robotic surgery are the commonly practices surgical techniques while performing minimally invasive surgeries for the treatment of prostate cancer. Factors such as increasing prevalence of prostate cancer, increasing product approvals, and increasing investment in research and development are expected to propel the market growth during the forecast period.
Key features of the study:
Detailed Segmentation:
North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Product Type:
North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Application:
North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Region:
Company Profiles
Key features of the study:
- This report provides in-depth analysis of the North America and Europe Minimally Invasive Prostate Cancer Surgery market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the North America and Europe Minimally Invasive Prostate Cancer Surgery market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Angiodynamics, Inc., Profound Medical, BSD Medical Corporation, Medtronic Plc, Ethicon Endo-Surgery, Inc., Olympus Corporation, Siemens Healthcare, Intuitive Surgical, Inc., and Teleflex, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The North America and Europe Minimally Invasive Prostate Cancer Surgery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America and Europe Minimally Invasive Prostate Cancer Surgery market
Detailed Segmentation:
North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Product Type:
- Hand
- Resectoscope
- Linear Cutter
- Insufflators
- Curved Stapler
- Endoscopic Trocars
- Prostatic Retractor
- Cryoablation Device
- Others
- Monitoring & Visualization
- Cameras & Video Support
- Endoscopic Trocars with Optical View
- Powered
- Electrosurgical Unit
- Lasers
North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Application:
- Laparoscopy
- Robotics Surgery
- Brachytherapy
- Cryosurgery
North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- Angiodynamics, Inc. *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Profound Medical
- BSD Medical Corporation
- Medtronic Plc
- Ethicon Endo-Surgery, Inc.
- Olympus Corporation
- Siemens Healthcare
- Intuitive Surgical, Inc.
- Teleflex, Inc.
- “*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Product Type, 2019 - 2027, (US$ Mn)
5. North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Application, 2019 - 2027, (US$ Mn)
6. North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Region, 2019 - 2027, (US$ Mn)
7. Competitive Landscape
8. Section
Companies Mentioned
A selection of companies mentioned in this report includes:
- Angiodynamics, Inc.
- Profound Medical
- BSD Medical Corporation
- Medtronic Plc
- Ethicon Endo-Surgery, Inc.
- Olympus Corporation
- Siemens Healthcare
- Intuitive Surgical, Inc.
- Teleflex, Inc.
